| 000 | 01085 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250513115833.0 | ||
| 264 | 0 | _c19970604 | |
| 008 | 199706s 0 0 eng d | ||
| 022 | _a0190-9622 | ||
| 024 | 7 |
_a10.1016/s0190-9622(97)80347-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPellicano, R | |
| 245 | 0 | 0 |
_aFixed drug eruptions with feprazone are linked to HLA-B22. _h[electronic resource] |
| 260 |
_bJournal of the American Academy of Dermatology _cMay 1997 |
||
| 300 |
_a782-4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xadverse effects |
| 650 | 0 | 4 |
_aDrug Eruptions _xetiology |
| 650 | 0 | 4 |
_aFeprazone _xadverse effects |
| 650 | 0 | 4 |
_aHLA-B Antigens _xanalysis |
| 650 | 0 | 4 | _aHumans |
| 700 | 1 | _aLomuto, M | |
| 700 | 1 | _aCiavarella, G | |
| 700 | 1 | _aDi Giorgio, G | |
| 700 | 1 | _aGasparini, P | |
| 773 | 0 |
_tJournal of the American Academy of Dermatology _gvol. 36 _gno. 5 Pt 1 _gp. 782-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0190-9622(97)80347-7 _zAvailable from publisher's website |
| 999 |
_c9127913 _d9127913 |
||